Rangeley Capital »

Keros Therapeutics shares owned by Rangeley Capital

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.1M 259k 15.82
2025-06-30 $3.8M 285k 13.35
2025-03-31 $4.2M 408k 10.19